Cargando…
Safety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly malaria vivax treatment
BACKGROUND: Malaria remains a major public health problem, with half the world population at risk of contracting malaria. The effects of Plasmodium vivax on prosperity and longevity have been highlighted in several recent clinical case reports. The first line of vivax treatment drugs has seen no rad...
Autores principales: | Pereira, Dhelio, Daher, André, Zanini, Graziela, Maia, Ivan, Fonseca, Lais, Pitta, Luciana, Ruffato, Rosilene, Marchesini, Paola, Fontes, Cor Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027105/ https://www.ncbi.nlm.nih.gov/pubmed/27639847 http://dx.doi.org/10.1186/s12936-016-1530-0 |
Ejemplares similares
-
Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial
por: Daher, André, et al.
Publicado: (2018) -
Plasmodium vivax trophozoites insensitive to chloroquine
por: Sharrock, Wesley W, et al.
Publicado: (2008) -
Chloroquine-Resistant Plasmodium
vivax, Brazilian Amazon
por: Filho, Franklin Simoes de Santana, et al.
Publicado: (2007) -
Resistance of infection by Plasmodium vivax to chloroquine in Bolivia
por: Añez, Arletta, et al.
Publicado: (2015) -
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)